These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 28748294)

  • 1. [Clinical Trials with Medicinal Products : Changes imposed by the new Clinical Trial Regulation].
    Sudhop T; Krafft H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Aug; 60(8):793-794. PubMed ID: 28748294
    [No Abstract]   [Full Text] [Related]  

  • 2. [Approval of clinical trials with biological medicinal products].
    Gross S; Jost N; Hartmann JP
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Aug; 60(8):826-829. PubMed ID: 28677049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germany opposes EU plans for regulating clinical trials owing to lack of ethical standards.
    Tuffs A
    BMJ; 2012 Oct; 345():e6640. PubMed ID: 23033377
    [No Abstract]   [Full Text] [Related]  

  • 4. [The Therapeutic Drug Committee of German Physicians. 50 years in the service of drug safety in Germany].
    Müller-Oerlinghausen B; Tiaden JD
    Internist (Berl); 2002 Apr; 43(4):482, 485-92. PubMed ID: 12053404
    [No Abstract]   [Full Text] [Related]  

  • 5. [Off-label use in psychopharmacotherapy].
    Fritze J; Schmauss M
    Nervenarzt; 2002 Aug; 73(8):796-9. PubMed ID: 12242971
    [No Abstract]   [Full Text] [Related]  

  • 6. [The 12th German Drug Law (AMG) amendment: an obstruction for non-commercial clinical trials?].
    Schwarz S; Frölich L; Striebel JP; Hennerici MG
    Dtsch Med Wochenschr; 2007 Jan; 132(3):108-12. PubMed ID: 17219346
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in the German Medicinal Product Act imposed by the EU regulation on clinical trials].
    Nickel L; Seibel Y; Frech M; Sudhop T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Aug; 60(8):804-811. PubMed ID: 28664271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. India tries to improve national system for handling clinical trials.
    Sharma DC
    Lancet; 2001 May; 357(9269):1682. PubMed ID: 11425387
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical research with pharmaceutical agents in Germany: effects of the 12th amendment to the German Drug Law].
    Götte D; Weihrauch TR
    Internist (Berl); 2004 Jun; 45 Suppl 1():S48-54. PubMed ID: 15138642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug approval and clinical investigation: future aspects of German and European regulations.
    Anhalt E
    Methods Find Exp Clin Pharmacol; 1998; 20(6):539-46. PubMed ID: 9789877
    [No Abstract]   [Full Text] [Related]  

  • 11. Future developments of clinical research in pediatrics: the role of the Journal Klinische Pädiatrie.
    Körholz D; Gortner L; Göbel U
    Klin Padiatr; 2013 Jul; 225(4):191-2. PubMed ID: 23904155
    [No Abstract]   [Full Text] [Related]  

  • 12. [European network for investigation of medicinal products in children (Medichildren)].
    Pons G
    Arch Pediatr; 2006 Jun; 13(6):631. PubMed ID: 16713209
    [No Abstract]   [Full Text] [Related]  

  • 13. [Network for investigation of medicinal products in children].
    Kassaï B; Treluyer JM; Jacqz-Aigrain E; Pons G
    Arch Pediatr; 2006 Jun; 13(6):631-4. PubMed ID: 16697606
    [No Abstract]   [Full Text] [Related]  

  • 14. [Implementation status of Regulation EU 536/2014 in the member states].
    Stahl E
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Aug; 60(8):836-840. PubMed ID: 28638933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [GCP inspections of clinical trials].
    Schwarz G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Feb; 48(2):181-8. PubMed ID: 15726459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical trials in children--between the expectations of scientific requirements, the assurance of proven treatment and ethical demands].
    Lehmann B; Mentzer D; Fischer T; Mallinckrodt-Pape K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Apr; 52(4):410-6. PubMed ID: 19266173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Regulation on Pediatric Psoriasis Drug Approvals: The Challenge of the European Union Pediatric Investigation Plans.
    Rose K; Happle R
    Pediatr Dermatol; 2017 May; 34(3):e154-e159. PubMed ID: 28523878
    [No Abstract]   [Full Text] [Related]  

  • 18. [Safety monitoring of cell-based medicinal products (CBMPs)].
    Funk MB; Frech M; Spranger R; Keller-Stanislawski B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Nov; 58(11-12):1239-46. PubMed ID: 26391098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical trials in Germany and in the EU in the new legislative environment. An analysis from the industry's point of view].
    Heidenreich K; Möritz A; Löffler H; Oberle-Rolle B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr; 48(4):415-22. PubMed ID: 15830252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reforming the EU environment for clinical trials: what are the challenges?
    Fears R; Blum HE; Kelleher D; Meunier F; Souhami R
    QJM; 2013 Sep; 106(9):787-9. PubMed ID: 23893498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.